These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17937861)

  • 21. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
    Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Chinese herbal medicine Ningdong granule on regulating dopamine (DA)/serotonin (5-TH) and gamma-amino butyric acid (GABA) in patients with Tourette syndrome.
    Wang S; Qi F; Li J; Zhao L; Li A
    Biosci Trends; 2012 Aug; 6(4):212-8. PubMed ID: 23006968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.
    Darmani NA; Martin BR; Glennon RA
    Eur J Pharmacol; 1990 Sep; 186(1):115-8. PubMed ID: 2282932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhynchophylline Attenuates Neurotoxicity in Tourette Syndrome Rats.
    Hongyan L; Mengjiao Z; Chunyan W; Yaruo H
    Neurotox Res; 2019 Nov; 36(4):679-687. PubMed ID: 31115771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol.
    Shireen E; Qurrat-ul-Ain ; Batool F; Saify ZS; Haleem DJ
    Pak J Pharm Sci; 2002 Jan; 15(1):71-82. PubMed ID: 16414870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical symptomatology, CSF neurotransmitter metabolites, and serum haloperidol levels in Tourette syndrome.
    Singer HS; Tune LE; Butler IJ; Zaczek R; Coyle JT
    Adv Neurol; 1982; 35():177-83. PubMed ID: 6959488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactobacillus plantarum PS128 ameliorates 2,5-Dimethoxy-4-iodoamphetamine-induced tic-like behaviors via its influences on the microbiota-gut-brain-axis.
    Liao JF; Cheng YF; Li SW; Lee WT; Hsu CC; Wu CC; Jeng OJ; Wang S; Tsai YC
    Brain Res Bull; 2019 Nov; 153():59-73. PubMed ID: 31351942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of haloperidol on extracellular contents of dopamine and its metabolites in the septum of rats during interspecies aggression].
    Gaĭnetdinov RR; Gromov AI; Kudrin VS; Pletnikov MS
    Biull Eksp Biol Med; 1992 Sep; 114(9):231-3. PubMed ID: 1477338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
    Millan MJ; Schreiber R; Dekeyne A; Rivet JM; Bervoets K; Mavridis M; Sebban C; Maurel-Remy S; Newman-Tancredi A; Spedding M; Muller O; Lavielle G; Brocco M
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1356-73. PubMed ID: 9732399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of 5-HT2A/C receptors and DOI-induced behaviors by protein kinase Cgamma.
    Bowers BJ; Miyamoto-Ditmon J; Wehner JM
    Pharmacol Biochem Behav; 2006 Oct; 85(2):441-7. PubMed ID: 17109939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
    Haleem DJ; Shireen E; Haleem MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor.
    Holick KA; Lee DC; Hen R; Dulawa SC
    Neuropsychopharmacology; 2008 Jan; 33(2):406-17. PubMed ID: 17429410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors.
    Yasuda K; Suemaru K; Araki H; Gomita Y
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):276-81. PubMed ID: 12172711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gastrodin on the dopamine system of Tourette's syndrome rat models.
    Lv H; Li A; Liu F; Ma H; Yao B
    Biosci Trends; 2009 Apr; 3(2):58-62. PubMed ID: 20103948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A genetic screen for mouse mutations with defects in serotonin responsiveness.
    Weiss KC; Kim DY; Pawson CT; Cordes SP
    Brain Res Mol Brain Res; 2003 Jul; 115(2):162-72. PubMed ID: 12877987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
    Leckman JF; Cohen DJ
    Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.